The Comparison of Laryngeal Mask Airway and Endotracheal Tube in General Anesthesia for Premature Neonates
Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Apr 27, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The participant patients will be randomly allocated into two groups: the laryngeal mask airway group (LMA group) and endotracheal tube group (ETT group). Masking ventilation with sevoflurane will be used for anesthesia induction till the adequate anesthetic depth. Intubation with laryngeal mask airway (LMA) or endotracheal tube (ETT) will be done as allocated group. After the surgery completed and the patient wakened up, the anesthesiologist will remove the LMA or ETT according to the clinical criteria for extubation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • preterm neonates (gestational age \< 37 weeks) in our neonatal ward scheduled to receive unilateral or bilateral inguinal hernia repair surgery, and whose body weight \> 2000g at surgery
- Exclusion Criteria:
- • emergent surgery, infants who was intubated before surgery, long-term oxygen or mechanical ventilation dependence, severe congenital cardiopulmonary disease, lacking of birth history, combination with other major surgery, postmenstrual age \> 52 weeks at surgery
About Kaohsiung Medical University Chung Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital is a leading healthcare institution in Taiwan, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital leverages its extensive expertise in various medical disciplines, state-of-the-art facilities, and a multidisciplinary team of professionals to conduct rigorous clinical studies. Committed to ethical standards and patient safety, the hospital collaborates with academic institutions and industry partners to facilitate groundbreaking research that contributes to the global medical community and enhances treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Patients applied
Trial Officials
Miaopei Su, Master
Principal Investigator
Kaohsiung Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials